| 臺大學術典藏 |
2021-01-27T06:53:36Z |
SiO2 supported niobium oxides with active acid sites for the catalytic acetalization of glycerol
|
Kao, L.C.;Kan, W.C.;Martin-Aranda, R.M.;Guerrero-Perez, M.O.;Bañares, M.Á.;Liou, S.Y.H.; Kao, L.C.; Kan, W.C.; Martin-Aranda, R.M.; Guerrero-Perez, M.O.; Bañares, M.Á.; Liou, S.Y.H.; YA-HSUAN LIOU |
| 臺大學術典藏 |
2021-01-27T03:23:37Z |
SiO2 supported niobium oxides with active acid sites for the catalytic acetalization of glycerol
|
Kao, L.C.;Kan, W.C.;Martin-Aranda, R.M.;Guerrero-Perez, M.O.;Bañares, M.Á.;Liou, S.Y.H.; Kao, L.C.; Kan, W.C.; Martin-Aranda, R.M.; Guerrero-Perez, M.O.; Bañares, M.Á.; Liou, S.Y.H.; YA-HSUAN LIOU |
| 臺大學術典藏 |
2021-01-12T03:32:23Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Lin Y.-F.; Chen Y.-M.; Hung K.-Y.; Chu T.-S.; Kan W.-C.; Huang C.-Y.; SHUEI-LIONG LIN; Kao T.-W.; Huang J.-W.; Chiang W.-C.; Yen C.-J.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2020-12-24T08:38:30Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Lin Y.-F.; Lin Y.-F.;Chen Y.-M.;Hung K.-Y.;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Huang J.-W.;Wen-Chih Chiang;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Wu M.-S.; Wu M.-S.; Wu K.-D.; Tsai T.-J.; Yen C.-J.; Chen Y.-M.; Hung K.-Y.; Chu T.-S.; Kan W.-C.; Huang C.-Y.; Lin S.-L.; Kao T.-W.; Huang J.-W.; WEN-CHIH CHIANG |
| 臺大學術典藏 |
2020-12-24T08:11:52Z |
Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: A randomized, open-label, parallel-group study
|
Lin Y.-F.;Chien C.-T.;Kan W.-C.;Chen Y.-M.;Chu T.-S.;Hung K.-Y.;Tsai T.-J.;Wu K.-D.;Ming-Shiou Wu; Lin Y.-F.; Chien C.-T.; Kan W.-C.; Chen Y.-M.; Chu T.-S.; Hung K.-Y.; Tsai T.-J.; Wu K.-D.; MING-SHIOU WU |
| 臺大學術典藏 |
2020-12-24T08:11:52Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
MING-SHIOU WU; Wu K.-D.; Tsai T.-J.; Chiang W.-C.; Yen C.-J.; Huang J.-W.; Kao T.-W.; Lin S.-L.; Huang C.-Y.; Kan W.-C.; Chu T.-S.; Hung K.-Y.; Chen Y.-M.; Lin Y.-F.; Lin Y.-F.;Chen Y.-M.;Hung K.-Y.;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Huang J.-W.;Chiang W.-C.;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Ming-Shiou Wu |
| 臺大學術典藏 |
2020-12-24T07:43:47Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Wu K.-D.; Wu M.-S.; TUN-JUN TSAI; Yen C.-J.; Chiang W.-C.; Huang J.-W.; Kao T.-W.; Lin S.-L.; Huang C.-Y.; Kan W.-C.; Chu T.-S.; Hung K.-Y.; Chen Y.-M.; Lin Y.-F. |
| 臺大學術典藏 |
2020-12-24T07:43:45Z |
Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: A randomized, open-label, parallel-group study
|
Lin Y.-F.; Chien C.-T.; Kan W.-C.; Chen Y.-M.; Chu T.-S.; Hung K.-Y.; TUN-JUN TSAI; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2020-12-24T07:01:36Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Wu M.-S.; Wu K.-D.; Tsai T.-J.; Chiang W.-C.; Yen C.-J.; JENQ-WEN HUANG; Kao T.-W.; Lin S.-L.; Huang C.-Y.; Kan W.-C.; Chu T.-S.; Hung K.-Y.; Chen Y.-M.; Lin Y.-F.; Lin Y.-F.;Chen Y.-M.;Hung K.-Y.;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Jenq-Wen Huang;Chiang W.-C.;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Wu M.-S. |
| 臺大學術典藏 |
2020-12-24T07:01:21Z |
Proteinuria as a Therapeutic Target in Advanced Chronic Kidney Disease: A Retrospective Multicenter Cohort Study
|
Chen C.-H.;Wu H.-Y.;Wang C.-L.;Yang F.-J.;Wu P.-C.;Hung S.-C.;Kan W.-C.;Yang C.-W.;Chiang C.-K.;Jenq-Wen Huang;Hung K.-Y.; Chen C.-H.; Wu H.-Y.; Wang C.-L.; Yang F.-J.; Wu P.-C.; Hung S.-C.; Kan W.-C.; Yang C.-W.; Chiang C.-K.; JENQ-WEN HUANG; Hung K.-Y. |
